Journal profile · Peripheral Vascular Disease
Hypertension Research
ISSN 0916-9636 · eISSN 1348-4214 · Springer Nature · JAPAN · Monthly · Founded 2005
Hypertension Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.02; hybrid open access; APC about USD 3,090; median 50 days to acceptance (113 articles, last 24 months); community-reported acceptance: easy; 425 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hypertension Research is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention and Hormonal Regulation and Hypertension, together about 41.4% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Hypertension Research is the official journal of the Japanese Society of Hypertension, publishing high-quality original research articles, reviews, correspondence and editorials on all aspects of hypertension and related cardiovascular diseases. The journal publishes papers on clinical trials, clinical and epidemiological studies and basic research (e.g. pathophysiology, genetics, metabolomics, pharmacology, molecular biology, and biomarkers). We have recently expanded the journal’s scope. It now includes organ damage, vascular dysfunction, cerebrovascular disease, chronic kidney disease, metabolic diseases, and important issues in specific populations such as the elderly (cognitive dysfunction, frailty), children, pregnant women, cancer patients etc. Moreover, papers on outcome research concerning hypertension and its management and the use of emerging technologies such as telemedicine, big data analysis, wearable devices, artificial intelligence (AI), and other digital technologies are also welcome.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine22.6%
- Cardiovascular Health and Disease PreventionMedicine9.4%
- Hormonal Regulation and HypertensionMedicine9.4%
- Heart Rate Variability and Autonomic ControlMedicine8.7%
- Sodium Intake and HealthNursing6.8%
- Renin-Angiotensin System StudiesMedicine5.8%
- Nutritional Studies and DietMedicine3.3%
- Birth, Development, and HealthMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedCurrent ContentsPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.02LetPub ·
- Impact factor (publisher) 2025
- 5Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.4Publisher website ·
- CiteScore 2026-06
- 8.2LetPub ·
- SJR 2026-06
- 1.36LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 78LetPub ·
- h-index
- 126OpenAlex ·
- i10-index
- 3,434OpenAlex ·
- 2-year mean citedness
- 3.85OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 28.42%LetPub ·
Volume
- Articles per year
- 216LetPub ·
- Downloads per year (publisher) 2025
- 4,813,228Publisher website ·
Articles by year OpenAlex count · 6,346 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 306 | 124 | 221 |
| 2025 | 425 | 220 | 1,153 |
| 2024 | 529 | 306 | 3,477 |
| 2023 | 405 | 225 | 4,217 |
| 2022 | 305 | 159 | 4,116 |
| 2021 | 242 | 166 | 3,534 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
50 daysMedian, submission to acceptance · P25–P75 12 days – 123 days
- Acceptance to online
- median 21 days (113 articles)
- Submission to online
- median 76 days
- Sample
- 113 articles with submission and acceptance dates (919 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 4,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- JAPAN
- Language
- English
- Frequency
- Monthly
- Founded
- 2005
- ISSN
- 0916-9636
- Electronic ISSN
- 1348-4214
- Society / sponsor
- Japanese Society of Hypertension
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Hypertension Research
What CAS zone is Hypertension Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hypertension Research is in Zone 3 of Medicine, and in Zone 3 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hypertension Research?
The latest impact factor listed by LetPub is 5.02; CiteScore 8.2, h-index 126.
How long does peer review take at Hypertension Research?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 50 days (interquartile range 12–123 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Hypertension Research?
According to LetPub and DOAJ records, Hypertension Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed and Current Contents; that list has not been checked against each database.
Is Hypertension Research open access, and what is the APC?
Hypertension Research is a hybrid journal. For open-access publication: APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .